A new study published in JAMA Psychiatry linked GLP-1 receptor agonists like Ozempic with a lower risk of alcohol-related ...

Ozempic can help with blood sugar management, aid with significant weight loss, and perhaps even treat opioid use disorder.

A new study has found that weight loss drugs may significantly reduce the consumption of alcohol in those with alcohol use ...

GLP-1 receptor agonists, a diabetic medication may help in reducing alcohol consumption and alcohol-related health problems.

There has been a lot of excitement since the launch. Not only is the drug extremely effective (people lose about 15 percent ...

Good afternoon, and welcome to Fractyl Health's Third Quarter Financial Results and Business Updates Call. As a reminder, this conference call is being recorded. [Operator Instructions]. I will now ...

Effective treatments for alcohol dependence exist; however, they remain underused and are not effective, or suitable, for all ...

The weight-loss jab Wegovy made its debut on June 4 2021 . It was the first new weight-loss drug to be approved by the US ...

Amgen has spoken out about concerns related to bone mineral density (BMD) loss with its obesity candidate after an analyst’s comment caused a $12bn market wipe.

Hims & Hers introduced a new tracker to monitor shortages of GLP-1 weight loss and diabetes drugs, responding to the FDA's decision to end the compounded versions, Yahoo Finance reported Nov. 13.

Eli Lilly's tirzepatide cut the risk of developing type 2 diabetes for people with pre-diabetes by 94%, according to new ...